Learn more

YEDA RES & DEV

Overview
  • Total Patents
    7,674
  • GoodIP Patent Rank
    1,420
  • Filing trend
    ⇩ 1.0%
About

YEDA RES & DEV has a total of 7,674 patent applications. It decreased the IP activity by 1.0%. Its first patent ever was published in 1962. It filed its patents most often in Israel, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GENOMIX CO LTD, YISSUM RES DEV CO and NAT JEWISH MED & RES CENTER.

Patent filings per year

Chart showing YEDA RES & DEVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wallach David 371
#2 Cohen Irun R 326
#3 Rubinstein Menachem 217
#4 Eisenbach-Schwartz Michal 204
#5 Reisner Yair 185
#6 Fridkin Matityahu 156
#7 Revel Michel 153
#8 Arnon Ruth 144
#9 Scherz Avigdor 140
#10 Shinitzky Meir 137

Latest patents

Publication Filing date Title
IL279607D0 Liposomes-containing antifouling compositions and uses thereof
WO2021059269A1 Assembly of protein complexes on a chip
WO2021048852A1 Methods of treating breast cancer
WO2021024264A2 Anti-viral central memory cd8+ veto cells in haploidentical stem cell transplantation
US2021038166A1 Method and system for predicting childhood obesity
WO2021024253A1 Process for the preparation of fluensulfone
WO2021009763A1 Methods of treating pain
WO2021001836A1 System and method for generating an image
WO2020255124A1 Method for stabilizing intracellular rna
US2020303135A1 Energy storage devices
US2020373018A1 Method of diagnosing pathogenesis of viral infection for epidemic prevention
IL275141D0 Bacteriophage containing compositions and uses thereof in treating acne and biofilms
WO2020240543A1 Method and system for predicting gestational diabetes
WO2020230133A1 Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
WO2020222241A1 Compositions comprising the propeptide of lysyl oxidase and uses thereof
WO2020222234A1 Multi-color electrochromic devices
WO2020212985A1 Extracellular vesicles derived from activated car-t cells
WO2020212979A1 Molecular switches in porous networks
WO2020202157A1 Plant expressing animal milk proteins
WO2020202142A2 Anti-viral and anti-tumoral compounds